Lilly Humatrope Short Stature Prescribing Criteria Recommended By Cmte.

Lilly should develop prescribing criteria to guide the use of Humatrope for non-growth hormone deficient short stature in pediatric patients, members of FDA's Endocrinologic & Metabolic Drugs Advisory Committee suggested during a June 10 meeting

More from Archive

More from Pink Sheet